GB202213663D0 - Aerosolisable formulation - Google Patents

Aerosolisable formulation

Info

Publication number
GB202213663D0
GB202213663D0 GBGB2213663.4A GB202213663A GB202213663D0 GB 202213663 D0 GB202213663 D0 GB 202213663D0 GB 202213663 A GB202213663 A GB 202213663A GB 202213663 D0 GB202213663 D0 GB 202213663D0
Authority
GB
United Kingdom
Prior art keywords
aerosolisable formulation
aerosolisable
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2213663.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RAI Strategic Holdings Inc
Original Assignee
RAI Strategic Holdings Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RAI Strategic Holdings Inc filed Critical RAI Strategic Holdings Inc
Priority to GBGB2213663.4A priority Critical patent/GB202213663D0/en
Publication of GB202213663D0 publication Critical patent/GB202213663D0/en
Priority to PCT/IB2023/059132 priority patent/WO2024057248A1/en
Priority to TW112135105A priority patent/TW202412648A/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/10—Chemical features of tobacco products or tobacco substitutes
    • A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
    • A24B15/167—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes in liquid or vaporisable form, e.g. liquid compositions for electronic cigarettes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
GBGB2213663.4A 2022-09-16 2022-09-16 Aerosolisable formulation Ceased GB202213663D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB2213663.4A GB202213663D0 (en) 2022-09-16 2022-09-16 Aerosolisable formulation
PCT/IB2023/059132 WO2024057248A1 (en) 2022-09-16 2023-09-14 Aerosolisable formulation
TW112135105A TW202412648A (en) 2022-09-16 2023-09-14 Aerosolisable formulation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2213663.4A GB202213663D0 (en) 2022-09-16 2022-09-16 Aerosolisable formulation

Publications (1)

Publication Number Publication Date
GB202213663D0 true GB202213663D0 (en) 2022-11-02

Family

ID=84817780

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2213663.4A Ceased GB202213663D0 (en) 2022-09-16 2022-09-16 Aerosolisable formulation

Country Status (3)

Country Link
GB (1) GB202213663D0 (en)
TW (1) TW202412648A (en)
WO (1) WO2024057248A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150013695A1 (en) * 2013-07-10 2015-01-15 Ahkeo Ventures LLC Inhalable compositions comprising caffeine, methods of use and an apparatus for using the same
KR20230047149A (en) * 2020-09-03 2023-04-06 레이 스트라티직 홀딩스, 인크. Aerosolizable formulations

Also Published As

Publication number Publication date
TW202412648A (en) 2024-04-01
WO2024057248A1 (en) 2024-03-21

Similar Documents

Publication Publication Date Title
GB202007546D0 (en) Formulation
IL307849A (en) Sotorasib formulation
GB202318884D0 (en) Formulation
GB202316857D0 (en) Cannabinoid-based formulation
GB202312814D0 (en) Formulation
GB202312220D0 (en) Formulation
GB202311622D0 (en) Formulation
GB202311439D0 (en) Formulation
GB202308224D0 (en) Formulation
GB202307003D0 (en) Cannabinoid-based formulation
GB202307002D0 (en) Cannabinoid-based formulation
GB202306990D0 (en) Cannabinoid-based formulation
GB202306995D0 (en) Cannabinoid-based formulation
GB202303663D0 (en) Aerosolisable formulation
GB202218160D0 (en) Formulation
GB202217857D0 (en) Formulation
GB202217267D0 (en) Aerosolisable formulation
GB202217148D0 (en) Formulation
GB202216335D0 (en) Formulation
GB202213663D0 (en) Aerosolisable formulation
GB202211203D0 (en) Formulation
GB202209298D0 (en) Aerosolisable formulation
GB202211231D0 (en) Novel formulation
GB202206151D0 (en) Novel formulation
IL308046A (en) Alpelisib formulation

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)